NCT00261391View on ClinicalTrials.gov

Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

October 31, 2007

Conditions
Vascular Anomalies
Interventions
DRUG

Marimastat

Trial Locations (1)

02115

Childrens Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT00261391 - Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. | Biotech Hunter | Biotech Hunter